WASHINGTON--(BUSINESS WIRE)--invendo medical GmbH (www.invendo-medical.com), an emerging medical device company, announced today that it will disclose clinical data at Digestive Disease Week® 2007 from a pilot study using its breakthrough technology—called the invendoscope™ SC40, which is CE-marked and hence approved for sale in Europe, with market launch expected in 2008—that demonstrates patients can undergo a colonoscopy without sedation and still feel no pain. (Podcast available at www.medtechmatters.com.) DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
